Richard Sallie
- Hepatology top 0.5%
- Epidemiology top 2%
- Pharmacology top 1%
- Infectious Diseases top 5%
- Molecular Biology
- Co-authors
- Adrian M. Di BisceglieJay H. HoofnagleJ. Michael TredgerRoger W. WilliamsDavid E. KleinerHari S. ConjeevaramMichael FriedYoon Park
- Topics
- Hepatitis C virus research (25 papers)Hepatitis B Virus Studies (22 papers)Liver Disease Diagnosis and Treatment (14 papers)
- Cited by
- HepatologyEpidemiologyPharmacology
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Richard Sallie
47 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 109
- Hepatology 1.4k
- Epidemiology 1.4k
- Pharmacology 346
- Infectious Diseases 296
- Molecular Biology 241
Countries citing papers authored by Richard Sallie
This map shows the geographic impact of Richard Sallie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Sallie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Sallie more than expected).
Fields of papers citing papers by Richard Sallie
This network shows the impact of papers produced by Richard Sallie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Sallie. The network helps show where Richard Sallie may publish in the future.
Co-authorship network of co-authors of Richard Sallie
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Sallie. A scholar is included among the top collaborators of Richard Sallie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Sallie. Richard Sallie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | HFE Genotyping of a Western Australian genetic haemochromatosis population | 1 |
| 4 | 30 | |
| 5 | Ribavirin as Therapy for Chronic Hepatitis C | 72 |
| 6 | 14 | |
| 7 | 1 | |
| 8 | 38 | |
| 9 | 8 | |
| 10 | 24 | |
| 11 | 66 | |
| 12 | 38 | |
| 13 | 10 | |
| 14 | 99 | |
| 15 | 72 | |
| 16 | 20 | |
| 17 | 14 | |
| 18 | 66 | |
| 19 | 281 | |
| 20 | 18 |
About Richard Sallie
Richard Sallie is a scholar working on Hepatology, Epidemiology and Virology, having authored 48 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (22 papers) and Liver Disease Diagnosis and Treatment (14 papers). The work is most often cited by research in Hepatology (1.4k citations), Epidemiology (1.4k citations) and Pharmacology (346 citations). Richard Sallie has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Adrian M. Di Bisceglie, Jay H. Hoofnagle, J. Michael Tredger, Roger W. Williams, David E. Kleiner, Hari S. Conjeevaram, Michael Fried, Yoon Park, Valeria Tedeschi and Robin McKenzie. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.